info@chv.vc
129 South Street, 4th Floor, Boston, MA 02111
Augmenix, Inc. developed a hydrogel technology to improve outcomes in radiation oncology and surgery. These products decrease unintended radiation damage to normal organs during radiation therapy and mark soft tissue.